<a target="_blank" href="https://www.buzzsprout.com/twilio/text_messages/1035190/open_sms">Reach us by sending a text</a>

<a href="https://www.buzzsprout.com/twilio/text_messages/1035190/open_sms" rel="noopener noreferrer">Reach us by sending a text</a>

Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Business

Science

Life Sciences

BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.

Share Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD

Sign up to save your podcasts

Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD

Ep. 72 - Modality Matters: M&A Heats Up, Galbraith Maps AZ's BD

More shows like BioCentury This Week

Exchanges

WSJ What’s News

Bloomberg Intelligence

Odd Lots

Bloomberg Businessweek

The Readout Loud

The Journal.

Biotech 2050 Podcast

All-In with Chamath, Jason, Sacks & Friedberg

Business Of Biotech

Biotech Hangout

The Markets

Ground Truths

The Top Line

The BioCentury Show